Ophthalmologists may use nonmydriatic retinal imaging to supplement the standard clinical exam to screen diabetic children aged as young as 2 years, according to newly published research.
Ophthalmologists may use nonmydriatic retinal imaging to supplement the standard clinical exam to screen diabetic children aged as young as 2 years, according to newly published research.
US researchers conducted a prospective study of 106 children with type 1 diabetes who were aged 2 to 17 years. The study included an intake form; blood pressure, pulse and oximetry measurements; visual acuity assessment (Simav, Padova) and nonmydriatic colour imaging (CX-1 45° 15.1 megapixel camera, Canon). They assessed images for indications of diabetic retinopathy, and two clinicians graded image quality on a scale of 1 to 5.
Ninety-eight percent of the children underwent imaging. One was found to have nonproliferative diabetic retinopathy, and findings for 2 were incidental.
Sixty-two percent of the children had had an eye exam within the past year, with exams significantly more likely among older children and those who had had type 1 diabetes for more than 5 years.
Investigators graded images as high quality in 178 (86%) eyes, and they said images of some clinical value were obtained in 207 (99.5%) eyes.
The researchers shared their results in the Journal of Pediatric Ophthalmology and Strabismus.
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.